5'-Methyl-5'-(uracil-1-ylmethyl)-2'-oxo-3'-methylenetetrahydrofuran

ID: ALA3276956

PubChem CID: 12381709

Max Phase: Preclinical

Molecular Formula: C11H12N2O4

Molecular Weight: 236.23

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CC(C)(Cn2ccc(=O)[nH]c2=O)OC1=O

Standard InChI:  InChI=1S/C11H12N2O4/c1-7-5-11(2,17-9(7)15)6-13-4-3-8(14)12-10(13)16/h3-4H,1,5-6H2,2H3,(H,12,14,16)

Standard InChI Key:  JCMQJXWSRAZBTR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
   15.7084   -3.7208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7084   -4.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4204   -4.9542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1324   -4.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1324   -3.7208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4204   -3.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4204   -2.4792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9945   -4.9594    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4204   -5.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7059   -6.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9522   -5.8611    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4001   -6.4742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8126   -7.1888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6196   -7.0170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5797   -6.3880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4772   -7.9424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4167   -6.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  8  2  0
  3  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 12 15  2  0
 13 16  2  0
 10 17  1  0
M  END

Associated Targets(non-human)

W256 (236 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.23Molecular Weight (Monoisotopic): 236.0797AlogP: -0.20#Rotatable Bonds: 2
Polar Surface Area: 81.16Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.76CX Basic pKa: CX LogP: 0.37CX LogD: 0.37
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.57Np Likeness Score: 0.56

References

1. Lee KH, Wu YS, Hall IH..  (1977)  Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.,  20  (7): [PMID:874966] [10.1021/jm00217a009]

Source